NYU LANGONE HEALTH

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1841-01-01

Employees: 10K

Market Cap: -

Website: http://www.nyulangone.org

Clinical Trials

A Clinical Trial of Acamprosate for Treatment of Methamphetamine Addiction

Phase 1

Completed

Conditions: Methamphetamine Dependence, Treatment Seeking

Interventions: Drug: placebo
Drug: Acamprosate

First Posted Date: 2007-12-12

Last Posted Date: 2017-03-24

Lead Sponsor: NYU Langone Health

Target Recruit Count: 72

Registration Number: NCT00571922

Locations: 🇺🇸
VA New York Harbor Healthcare System, MHAD clinic, New York, New York, United States

A Pilot Study of Metabolic Effects of Omentectomy

Phase 2

Terminated

Conditions: Confirmed Type 2 Diabetes Treated With Oral Agents and/or Only Diet Therapy
Patients Who Consented to Undergo Laparoscopic Gastric Banding Surgery for Weight Loss and Consent to Participate in This studyBMI ≥35 kg/m2
Age 18-64 Years

Interventions: Procedure: Omentectomy
Other: No intervention

First Posted Date: 2007-11-30

Last Posted Date: 2015-11-20

Lead Sponsor: NYU Langone Health

Target Recruit Count: 11

Registration Number: NCT00565799

Locations: 🇺🇸
NYU School of Medicine, NY, New York, United States

A Pilot Study of Aerosol Interferon-gamma for Treatment of Idiopathic Pulmonary Fibrosis

Phase 1

Completed

Conditions: Pulmonary Fibrosis

Interventions: Drug: aerosol interferon-gamma

First Posted Date: 2007-11-26

Last Posted Date: 2020-04-28

Lead Sponsor: NYU Langone Health

Target Recruit Count: 12

Registration Number: NCT00563212

Locations: 🇺🇸
Division of Pulmonary & Critical Care Medicine, NYU School of Medicine, New York, New York, United States

Immediate vs. Delayed Insertion of Copper T 380A IUD After Termination of Pregnancy Over 12-weeks Gestation

Not Applicable

Completed

Conditions: Contraception Behavior

Interventions: Device: Copper T 380A IUD

First Posted Date: 2007-10-05

Last Posted Date: 2015-02-09

Lead Sponsor: NYU Langone Health

Target Recruit Count: 215

Registration Number: NCT00540046

Locations: 🇺🇸
Bellevue Hospital, New York, New York, United States
🇺🇸
Parkmed Women's Clinic, New York, New York, United States

Improving Parental Understanding of Medication Instructions Through a Pictogram-Based Intervention

Phase 1

Completed

Conditions: Medication Errors

Interventions: Other: Pictogram

First Posted Date: 2007-10-01

Last Posted Date: 2007-10-01

Lead Sponsor: NYU Langone Health

Target Recruit Count: 251

Registration Number: NCT00537433

Locations: 🇺🇸
NYU School of Medicine Department of Pediatrics, New York, New York, United States

Microvascular Ultrasonographic Imaging for the Detection of Early Stage Epithelial Ovarian Carcinoma

Completed

Conditions: Ovarian Neoplasms

First Posted Date: 2007-09-19

Last Posted Date: 2010-09-23

Lead Sponsor: NYU Langone Health

Target Recruit Count: 100

Registration Number: NCT00531570

Locations: 🇺🇸
NYU Cancer Institute, New York, New York, United States

NYU Ovarian Cancer Early Detection Program Blood and Genetics

Terminated

Conditions: Ovarian Cancer

First Posted Date: 2007-09-19

Last Posted Date: 2011-01-11

Lead Sponsor: NYU Langone Health

Target Recruit Count: 890

Registration Number: NCT00531778

Locations: 🇺🇸
NYUCancer Institute Clinical Cancer Center, New York, New York, United States

Temozolomide,Thiotepa and Carboplatin With Autologous Stem Cell Rescue Followed by 13-cis-retinoic Acid in Patients With Recurrent/Refractory Malignant Brain Tumors

Phase 2

Completed

Conditions: Brain Tumors

Interventions: Drug: temozolomide, thiotepa, carboplatin, 13-cis-retinoic acid

First Posted Date: 2007-09-12

Last Posted Date: 2021-07-08

Lead Sponsor: NYU Langone Health

Target Recruit Count: 46

Registration Number: NCT00528437

Locations: 🇺🇸
Children's Memorial Hospital, Chicago, Illinois, United States
🇺🇸
Children's Medical Center of Dallas, Dallas, Texas, United States
🇺🇸
MD Anderson Cancer Center (MDACC), Houston, Texas, United States

and more 14 locations

Double Blind Study of Vigabatrin for the Treatment of Cocaine Dependence

Phase 2

Completed

Conditions: Cocaine Dependence

Interventions: Drug: Placebo
Drug: Vigabatrin
Behavioral: Group therapy

First Posted Date: 2007-09-11

Last Posted Date: 2008-04-11

Lead Sponsor: NYU Langone Health

Target Recruit Count: 100

Registration Number: NCT00527683

Locations: 🇲🇽
Clinica Integral de Tratamiento Contra las Adicciones SA de CV, Mexico City, Mexico, D.F., Mexico

Remote Simultaneous Medical Interpreting and Medical Outcomes

Not Applicable

Completed

Conditions: DIabetes

Interventions: Other: remote simultaneous medical interpreting
Other: ENglish speaking
Other: usual and customary

First Posted Date: 2007-08-29

Last Posted Date: 2015-07-07

Lead Sponsor: NYU Langone Health

Target Recruit Count: 1200

Registration Number: NCT00522327

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy